Alamar Biosciences
ALMRHealthcare · Medical Devices · US26.48USDAlamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases.
1D−7.7%1W−14.1%1M−15.8%
Loading chart…
Checks
- Locked: Price trend
- Locked: Sales growth against its peers
- Locked: Profit against similar companies
- Locked: What analysts expect
- Locked: Price against what it earns
- Locked: Last quarter against forecasts
See how Alamar Biosciences does on each check. Sign in for two weeks free, with no card. Then StratDeck Pro is £5.99 a month or £60 a year.
Sign in